The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional AnalysisMaria Schubert, Martin Spahn, Claus Jürgen Scholz et al.|Advances in Urology|2012Cited by 9
Weekly combination of oxaliplatin (OX) and irinotecan (IRI) in 5-FU resistant colorectal cancer (CRC)Albrecht Kretzschmar, Peter Reichardt, Peter Thuss‐Patience et al.|European Journal of Cancer|2001Cited by 4